Skip to main content

3 Result(s)

within Chueh-Chuan Yen Remove this filter Medicine & Public Health Remove this filter Internal Medicine Remove this filter

and

  1. No Access

    Article

    Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: Superior progression-free survival is restricted to patients with measurable tumors and objective tumor response—a retrospective study

    We aimed to compare the treatment efficacy of cetuximab versus bevacizumab in combination with either irinotecan-based or oxaliplatin-based regimens (targeted triplet) as the first-line treatment for patients...

    Yuan-Hao Yang, Jen-Kou Lin, Wei-Shone Chen… in Journal of Cancer Research and Clinical On… (2014)

  2. No Access

    Article

    Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism

    A dozen clinical trials examining a combination of temsirolimus and cetuximab in treating metastatic colon cancer are currently underway. We investigated the role of cancerous inhibitor of protein phosphatase ...

    Hsei-Wei Wang, Shung-Haur Yang… in Journal of Cancer Research and Clinical On… (2014)

  3. No Access

    Article

    Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer

    The response to chemotherapy of solid tumors is generally assessed by measuring tumors visualized by imaging. However, the response assessment based on imaging is not always feasible because patients often hav...

    Wei-Shu Wang, Jen-Kou Lin, Tzu-Chen Lin… in International Journal of Colorectal Disease (2001)